Arcutis Biotherapeutics, Inc.Arcutis Biotherapeutics, Inc.Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪1.09 B‬USD
‪−262.14 M‬USD
‪59.61 M‬USD
‪97.38 M‬
Beta (1Y)
2.98

About Arcutis Biotherapeutics, Inc.

CEO
Todd Franklin Watanabe
Headquarters
Westlake Village
Employees (FY)
296
Founded
2016
ISIN
US03969K1088
FIGI
BBG00QN8K4M4
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ARQT is 9.10 USD — it has decreased by 3.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Arcutis Biotherapeutics, Inc. stocks are traded under the ticker ARQT.
Arcutis Biotherapeutics, Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
ARQT stock is 12.09% volatile and has beta coefficient of 2.98. Check out the list of the most volatile stocks — is Arcutis Biotherapeutics, Inc. there?
One year price forecast for Arcutis Biotherapeutics, Inc. has a max estimate of 26.00 USD and a min estimate of 11.00 USD.
ARQT earnings for the last quarter are −0.73 USD per share, whereas the estimation was −0.91 USD resulting in a 20.11% surprise. The estimated earnings for the next quarter are −0.78 USD per share. See more details about Arcutis Biotherapeutics, Inc. earnings.
Arcutis Biotherapeutics, Inc. revenue for the last quarter amounts to ‪38.11 M‬ USD despite the estimated figure of ‪32.91 M‬ USD. In the next quarter revenue is expected to reach ‪11.41 M‬ USD.
Yes, you can track Arcutis Biotherapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
ARQT stock has fallen by 22.68% compared to the previous week, the month change is a 8.27% fall, over the last year Arcutis Biotherapeutics, Inc. has showed a 32.29% decrease.
ARQT net income for the last quarter is ‪−66.28 M‬ USD, while the quarter before that showed ‪−44.77 M‬ USD of net income which accounts for −48.07% change. Track more Arcutis Biotherapeutics, Inc. financial stats to get the full picture.
Today Arcutis Biotherapeutics, Inc. has the market capitalization of ‪1.09 B‬, it has increased by 33.30% over the last week.
No, ARQT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ARQT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Arcutis Biotherapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ARQT reached its all-time high on Mar 20, 2020 with the price of 40.88 USD, and its all-time low was 1.76 USD and was reached on Dec 1, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 296.00 employees. See our rating of the largest employees — is Arcutis Biotherapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Arcutis Biotherapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Arcutis Biotherapeutics, Inc. stock shows the sell signal. See more of Arcutis Biotherapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Arcutis Biotherapeutics, Inc. future price: according to them, ARQT price has a max estimate of 26.00 USD and a min estimate of 11.00 USD. Read a more detailed Arcutis Biotherapeutics, Inc. forecast: see what analysts think of Arcutis Biotherapeutics, Inc. and suggest that you do with its stocks.